Rivus Pharmaceuticals, Inc. — Form D
Rivus Pharmaceuticals, Inc. of CHARLOTTESVILLE, VA, a company, filed a Form D exempt-offering notice with the SEC on 2025-01-16. The offering totals $57.0M, of which $57.0M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2025-01-16
- Form: D
- Accession: 0001773293-25-000002
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $57.0M
- Amount sold: $57.0M
- Investors: 7
- Date of first sale: 2025-01-07
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-535494
Issuer
- Name: Rivus Pharmaceuticals, Inc.
- CIK: 0001773293
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 501 LOCUST AVENUE, SUITE 301, CHARLOTTESVILLE, VA, 22902
- Phone: 703-456-8000
Officers, directors & promoters (15)
| Name | Role | Location |
|---|
| Allen Cunningham | Director | Charlottesville, VA |
| Jayson Dallas | Director | Austin, TX |
| Francesco De Rubertis | Director | Charlottesville, VA |
| Derek DiRocco | Director | Boston, MA |
| Shaharyar Khan | Director | Charlottesville, VA |
| Erin Lavelle | Director | Charlottesville, VA |
| Ian Smith | Director | Charlottesville, VA |
| Rick Winningham | Director | Charlottesville, VA |
| Allen Cunningham | Executive Officer | Charlottesville, VA |
| Jayson Dallas | Executive Officer | Austin, TX |
| Shaharyar Khan | Executive Officer | Charlottesville, VA |
| Tom O'Neil | Executive Officer | Charlottesville, VA |
| Robert Schott | Executive Officer | Charlottesville, VA |
| Patrick Enright | Director | Menlo Park, CA |
| Nancy Hargreaves | Executive Officer | Charlottesville, VA |
Other filings by this issuer (3)
More